December 18, 2017 12:39 AM ET

Biotechnology

Company Overview of Covalys Biosciences AG

Key Executives for Covalys Biosciences AG

NameBoard RelationshipsTitleAge
Andreas Brecht Ph.D.No RelationshipsCo-Founder, Chief Executive Officer and Chief Technology Officer--
Nils Johnsson No RelationshipsCo-Founder--
Kai Johnsson Ph.D.3 RelationshipsCo-Founder and Director--
Patrik Sidler No RelationshipsCo-Founder and Director--
Henri Zinsli Ph.D., OEC6 RelationshipsCo-Founder and Chairman of the Board76

Covalys Biosciences AG Board Members*

NameBoard RelationshipsPrimary CompanyAge
Henri Zinsli Ph.D., OEC 6 RelationshipsCovalys Biosciences AG76
Kai Johnsson Ph.D. 3 RelationshipsCovalys Biosciences AG--
Diego Braguglia Ph.D. 56 RelationshipsVI Partners AG51
Patrick Schär 4 RelationshipsBV Holding AG--
View All Board Members

Covalys Biosciences AG Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
386.9K
Bonus
237.8K
Total Short Term Compensation
482.5K
Total Value of Options
18.1M
Compensation as of Fiscal Year
Covalys Biosciences AG CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Sunesis Pharmaceuticals, Inc. Announces Management Changes
December 15, 2017 10:09 PM ET
ContraFect Corporation Announces Executive Changes
December 15, 2017 9:52 PM ET
Biotoscana Investments S.A. Hires Ivan French as Executive Vice President of Research and Development
December 15, 2017 9:36 PM ET
Minerva Neurosciences, Inc. Announces Management Changes
December 15, 2017 9:31 PM ET
Applied Genetic Technologies Corporation Announces Resignation of R. Guyer from the Board
December 15, 2017 9:16 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Covalys Biosciences AG, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.